Richard Hoyt
Vorsitzender bei ZYUS LIFE SCIENCES CORPORATION
Vermögen: 117 687 $ am 30.04.2024
Profil
Richard Hoyt is currently the Chairman at ZYUS Life Sciences, Inc., Chairman at ZYUS Life Sciences Corp., Managing Partner at Ozark Transaction Advisors LLC, and Vice President-Business Development at Xeris Biopharma Holdings, Inc. He previously worked as the Director at Biotechnology Research & Development Corp., Independent Director at CanniMed Therapeutics, Inc. from 2012 to 2018, Vice President-Business Development at Xeris Pharmaceuticals, Inc., and Vice President-Business Development & Licensing at Mallinckrodt Plc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.06.2023 | 151 108 ( 0,21% ) | 117 687 $ | 30.04.2024 |
Aktive Positionen von Richard Hoyt
| Unternehmen | Position | Beginn |
|---|---|---|
| ZYUS LIFE SCIENCES CORPORATION | Vorsitzender | 01.09.2020 |
| XERIS BIOPHARMA HOLDINGS, INC. | Corporate Officer/Principal | - |
ZYUS Life Sciences, Inc.
 ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Vorsitzender | - |
| Ozark Transaction Advisors LLC | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Richard Hoyt
| Unternehmen | Position | Ende |
|---|---|---|
| CANNIMED THERAPEUTICS INC | Direktor/Vorstandsmitglied | 15.03.2018 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Corporate Officer/Principal | - |
Biotechnology Research & Development Corp.
 Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Direktor/Vorstandsmitglied | - |
| MALLINCKRODT PLC | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MALLINCKRODT PLC | Health Technology |
| XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
| ZYUS LIFE SCIENCES CORPORATION | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Biotechnology Research & Development Corp.
Biotechnology Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Biotechnology Research & Development Corp. provides research on animal and plant healthcare, material sciences and biotechnology. The company is headquartered in Peoria, IL. | Commercial Services |
CanniMed Therapeutics, Inc.
 CanniMed Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology CanniMed Therapeutics, Inc. operated as a biopharmaceutical company. It offered plant biotechnology research and product development programs. The firm focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications. The company was founded on Oct 31st, 2016 and was headquartered in Saskatoon, Canada. | Health Technology |
ZYUS Life Sciences, Inc.
ZYUS Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Zyus Life Sciences, Inc. operates as a life sciences company. It?s focused on the global development and commercialization of phyto-therapeutics, including cannabinoid and protein-based formulations. The firm offers pharmaceutical-grade phyto-therapeutics, forging new pathways in medicine, cannabinoids and extraction technology. The company was founded by Brent Zettl on April 3, 2018 and is headquartered in Saskatoon, Canada. | Health Technology |
| Ozark Transaction Advisors LLC |